Chengdu HitGen Pharmaceutical Development Co., Ltd. announced that its registration application for 400 million yuan of sci-tech innovation bonds has been accepted by the National Association of Financial Market Institutional Investors. The registration quota is valid for two years from the date of the notice, with Bank of Chengdu and Agricultural Bank of China as joint lead underwriters. The company may issue the bonds in tranches within the registration validity period. This matter has been reviewed and approved by the company's board of directors and extraordinary shareholders' meeting, and the issuance plan was revised in June 2026.
HitGen Inc. AHitGen's 400 million yuan sci-tech innovation medium-term note registration was accepted by NAFMII, giving it a new financing channel.
Agricultural Bank of China Ltd Class A
Bank of Chengdu Co Ltd